Arnaud Trébucq

High effectiveness of a 12-month regimen for MDR-TB patients in Cameroon

Christopher Kuaban, J Noeske, Hans L. Rieder et al. · The International Journal of Tuberculosis and Lung Disease · 2015 · 200 citations

Treatment outcome with a short multidrug-resistant tuberculosis regimen in nine African countries

Arnaud Trébucq, V Schwoebel, Zacharie Kashongwe et al. · The International Journal of Tuberculosis and Lung Disease · 2017 · 164 citations

Guidelines for conducting tuberculin skin test surveys in high prevalence countries

T. Arnadottir, H. L. Rieder, Arnaud Trébucq et al. · Tubercle and Lung Disease · 1996 · 140 citations

Tuberculosis Prevention, International Health, Tuberculosis +8

Xpert^® MTB/RIF for national tuberculosis programmes in low-income countries: when, where and how?

Arnaud Trébucq, Donald A. Enarson, Chen‐Yuan Chiang et al. · The International Journal of Tuberculosis and Lung Disease · 2011 · 127 citations

Point-of-care Testing, Xpert ® Mtb/rif, Tuberculosis Prevention +22

Assessment of Clofazimine Activity in a Second-Line Regimen for Tuberculosis in Mice

J Grosset, Sandeep Tyagi, Deepak V. Almeida et al. · American Journal of Respiratory and Critical Care Medicine · 2013 · 115 citations · Full text